Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

Avonex approval imminent

April 26, 1996

New antidepressants disclosed by Yamanouchi

April 26, 1996

Mitsui Seiyaku describes sigma-opioid antagonist

April 26, 1996

Sigma-opioid ligands from ADIR

April 26, 1996

U.S. government claims new antipsychotic compositions

April 26, 1996

IRI-695 for anxiety and depression

April 26, 1996

TAD-93 in preclinical studies for anxiety

April 26, 1996

New 5-HT1D antagonists from Pierre Fabre

April 26, 1996

SKB reports 5-HT2B/2C antagonists for CNS indications

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...